Global Alzheimers Disease Diagnostics and Therapeutics Market Size, Share, and COVID-19 Impact Analysis By Therapeutics (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Other Therapeutics), By Diagnostics (Brain Imaging and CSF Test for Alzheimers Disease), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.

Industry: Healthcare

RELEASE DATE Oct 2022
REPORT ID SI1226
PAGES 230
REPORT FORMAT PathSoft

  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Therapeutics
      2. Market Attractiveness Analysis  By Diagnostics
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Use of Biomarkers in Diagnosis and Drug Development
    3. Restraints
      1. Lack of Surrogate Markers and Challenges in Early Diagnosis
    4. Opportunities
      1. A large Number of Drugs on the Pipeline
    5. Challenges
      1. High Failure Rates of Late-stage Drugs
  6. Global Alzheimer's Disease Diagnostics and Therapeutics Market Analysis and Projection, By Therapeutics
    1. Segment Overview
    2. Cholinesterase Inhibitors
    3. NMDA Receptor Antagonists
    4. Other Therapeutics
  7. Global Alzheimer's Disease Diagnostics and Therapeutics Market Analysis and Projection,  By Diagnostics
    1. Segment Overview
    2. Brain Imaging
    3. CSF Test for Alzheimer’s Disease
  8. Global Alzheimer's Disease Diagnostics and Therapeutics Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Alzheimer's Disease Diagnostics and Therapeutics Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Alzheimer's Disease Diagnostics and Therapeutics Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Luye Pharma Group
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
  11. Vigil Neuroscience
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  12. Grifols SA
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  13. Corium International Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  14. Adamas Pharmaceuticals Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  15. Abbvie Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  16. Merz Pharma
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  17. Zydus Cadila
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  18. Siemens Healthineers AG
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  19. Apotex Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis

List of Table

  1. Global Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  2. Global Cholinesterase Inhibitors Alzheimer's Disease Diagnostics and Therapeutics Market, By Region, 2021-2030(USD Million)
  3. Global NMDA Receptor Antagonists Alzheimer's Disease Diagnostics and Therapeutics Market, By Region, 2021-2030(USD Million)
  4. Global Other Therapeutics Alzheimer's Disease Diagnostics and Therapeutics Market, By Region, 2021-2030(USD Million)
  5. Global Glucocorticoids Alzheimer's Disease Diagnostics and Therapeutics Market, By Region, 2021-2030(USD Million)
  6. Global Alkylating agents Alzheimer's Disease Diagnostics and Therapeutics Market, By Region, 2021-2030(USD Million)
  7. Global Interleukin inhibitors Alzheimer's Disease Diagnostics and Therapeutics Market, By Region, 2021-2030(USD Million)
  8. Global others  Alzheimer's Disease Diagnostics and Therapeutics Market, By Region, 2021-2030(USD Million)
  9. Global Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  10. Global Brain Imaging Alzheimer's Disease Diagnostics and Therapeutics Market, By Region, 2021-2030(USD Million)
  11. Global CSF Test for Alzheimer’s Disease Alzheimer's Disease Diagnostics and Therapeutics Market, By Region, 2021-2030(USD Million)
  12. North America Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  13. North America Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  14. U.S. Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  15. U.S. Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  16. Canada Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  17. Canada Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  18. Mexico Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  19. Mexico Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  20. Europe Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  21. Europe Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  22. Germany Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  23. Germany Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  24. France Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  25. France Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  26. U.K. Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  27. U.K. Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  28. Italy Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  29. Italy Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  30. Spain Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  31. Spain Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  32. Asia Pacific Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  33. Asia Pacific Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  34. Japan Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million) 
  35. Japan Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  36. China Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million) 
  37. China Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  38. India Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  39. India Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  40. South America Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  41. South America Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million) 
  42. Brazil Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  43. Brazil Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  44. The Middle East and Africa Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  45. The Middle East and Africa Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  46. UAE Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  47. UAE Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)
  48. South Africa Alzheimer's Disease Diagnostics and Therapeutics Market, By Therapeutics, 2021-2030(USD Million)
  49. South Africa Alzheimer's Disease Diagnostics and Therapeutics Market,  By Diagnostics, 2021-2030(USD Million)

 

List of Figures 

  1. Global Alzheimer's Disease Diagnostics and Therapeutics Market Segmentation
  2. Alzheimer's Disease Diagnostics and Therapeutics Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Alzheimer's Disease Diagnostics and Therapeutics Market
  9. Top Winning Strategies, 2021-2030
  10. Top Winning Strategies, By Development, 2021-2030(%)
  11. Top Winning Strategies, By Company, 2021-2030
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers: Alzheimer's Disease Diagnostics and Therapeutics Market
  20. Alzheimer's Disease Diagnostics and Therapeutics Market Segmentation, By Therapeutics
  21. Alzheimer's Disease Diagnostics and Therapeutics Market For Cholinesterase Inhibitors, By Region, 2022-2030 ($Million)
  22. Alzheimer's Disease Diagnostics and Therapeutics Market For NMDA Receptor Antagonists, By Region, 2022-2030 ($Million)
  23. Alzheimer's Disease Diagnostics and Therapeutics Market For Other Therapeutics, By Region, 2022-2030 ($Million)
  24. Alzheimer's Disease Diagnostics and Therapeutics Market Segmentation,  By Diagnostics
  25. Alzheimer's Disease Diagnostics and Therapeutics Market For Brain Imaging, By Region, 2022-2030 ($Million)
  26. Alzheimer's Disease Diagnostics and Therapeutics Market For CSF Test for Alzheimer’s Disease, By Region, 2022-2030 ($Million)
  27. Procter & Gamble: Net Sales, 2021-2030 ($Million)
  28. Procter & Gamble: Revenue Share, By Segment, 2022 (%)
  29. Procter & Gamble: Revenue Share, By Region, 2022 (%)
  30. PHYTOMER: Net Sales, 2021-2030 ($Million)
  31. PHYTOMER: Revenue Share, By Segment, 2022 (%)
  32. PHYTOMER: Revenue Share, By Region, 2022 (%)
  33. Deka Corporation: Net Sales, 2021-2030 ($Million)
  34. Deka Corporation: Revenue Share, By Segment, 2022 (%)
  35. Deka Corporation: Revenue Share, By Region, 2022 (%)
  36. Johnson & Johnson: Net Sales, 2021-2030 ($Million)
  37. Johnson & Johnson: Revenue Share, By Segment, 2022 (%)
  38. Johnson & Johnson: Revenue Share, By Region, 2022 (%)
  39. Unilever Plc.: Net Sales, 2021-2030 ($Million)
  40. Unilever Plc.: Revenue Share, By Segment, 2022 (%)
  41. Unilever Plc.: Revenue Share, By Region, 2022 (%)
  42. Kao Corporation: Net Sales, 2021-2030 ($Million)
  43. Kao Corporation: Revenue Share, By Segment, 2022 (%)
  44. Kao Corporation: Revenue Share, By Region, 2022 (%)
  45. ZO Skin Health, Inc.: Net Sales, 2021-2030 ($Million)
  46. ZO Skin Health, Inc.: Revenue Share, By Segment, 2022 (%)
  47. ZO Skin Health, Inc.: Revenue Share, By Region, 2022 (%)
  48. L’Oreal Paris: Net Sales, 2021-2030 ($Million)
  49. L’Oreal Paris: Revenue Share, By Segment, 2022 (%)
  50. L’Oreal Paris: Revenue Share, By Region, 2022 (%)
  51. Shiseido Company Limited: Net Sales, 2021-2030 ($Million)
  52. Shiseido Company Limited: Revenue Share, By Segment, 2022 (%)
  53. Shiseido Company Limited: Revenue Share, By Region, 2022 (%)
  54. Estee Lauder Companies, Inc.: Net Sales, 2021-2030 ($Million)
  55. Estee Lauder Companies, Inc.: Revenue Share, By Segment, 2022 (%)
  56. Estee Lauder Companies, Inc.: Revenue Share, By Region, 2022 (%)

 

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies